Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · IEX Real-Time Price · USD
0.148
-0.005 (-3.34%)
At close: Mar 28, 2024, 4:00 PM
0.147
-0.001 (-0.54%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Avenue Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-10.38-3.55-3.73-5.15-25.91-21.55-12.26-3.18-5.23
Share-Based Compensation
0.910.650.440.711.841.540.60.030.03
Other Operating Activities
0.02-4.69-0.46-0.17-2.191.84.851.524.3
Operating Cash Flow
-9.45-7.6-3.75-4.61-26.26-18.22-6.8-1.63-0.9
Capital Expenditures
000-100000
Change in Investments
0000010-1000
Other Investing Activities
-3--------3
Investing Cash Flow
-300-1010-100-3
Share Issuance / Repurchase
7.5310.545.04035037.9500
Debt Issued / Paid
000000-5.851.874.17
Other Financing Activities
---0.66--2.67-0.9-3.72-0.06-0.26
Financing Cash Flow
7.5310.544.38032.33-0.928.391.823.91
Net Cash Flow
-4.932.950.63-5.616.07-9.1111.590.180.01
Free Cash Flow
-9.45-7.6-3.75-5.61-26.26-18.22-6.8-1.63-0.9
Free Cash Flow Per Share
-0.89-3.48-3.31-5.10-25.05-26.68-15.38-8.56-4.97
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).